DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task

FDA's Office of the Chief Counsel has assigned two additional lawyers to review draft regulatory letters from the Division of Drug Marketing, Advertising & Communications

More from Archive

More from Pink Sheet